INVOKANA
- Product NDC
- 50090-4364
- 11-digit product format
- 500904364
- Labeler code
- 50090
- Product ID
- 50090-4364_8f7706b7-8c1b-4c13-bb18-3ec25c98425f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- canagliflozin
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- NDA204042
- Marketing category
- NDA
- Marketing start
- 2013-03-29
- Substance
- CANAGLIFLOZIN
- Active strength
- 300 mg/1
- Pharmacologic classes
- P-Glycoprotein Inhibitors [MoA], Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- INVOKANA
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| CANAGLIFLOZIN | 300 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 0SAC974Z85 |
| Rxcui | 1373471, 1373473 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 50090-4364-0 | INVOKANA | 90 in 1 BOTTLE | TABLET, FILM COATED | 90 | | 9 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 50090-4364 | INVOKANA (CANAGLIFLOZIN) TABLET, FILM COATED [A-S MEDICATION SOLUTIONS] | 9 | Current NDC, Legacy NDC, 1 package rows | 20231216_9679460c-55f7-4826-b55c-fe116f020358.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 50090-4364-0 | 50090436400 | 90 TABLET, FILM COATED in 1 BOTTLE (50090-4364-0) | 2019-06-17 | 0000-00-00 | No | No | Current |